The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world safety and effectiveness of trastuzumab deruxtecan (T-DXd) in HER2-overexpressing malignancies: A single-center retrospective study.
 
Sunny Cai
No Relationships to Disclose
 
Kirstin Binz
No Relationships to Disclose
 
Sanjana Mullangi
No Relationships to Disclose
 
Nahid Suleman
No Relationships to Disclose
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Jun Zhang
Consulting or Advisory Role - AstraZeneca; Fosun Pharma; Novocure; Regeneron; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; MJH Life Sciences; Regeneron; Sanofi
Research Funding - Abbvie (Inst); AstraZeneca; BeiGene (Inst); Bridgebio (Inst); Champions Oncology; Genentech/Roche; Hengrui Therapeutics (Inst); Innocare (Inst); Janssen (Inst); KAHR Medical (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics; Mirati Therapeutics (Inst); Nilogen Oncosystems; Novartis (Inst); Takeda
 
Raed Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Chao Huang
Stock and Other Ownership Interests - Vanguard Funds
Honoraria - Ipsen
Consulting or Advisory Role - Biodesix; Ipsen
Speakers' Bureau - Curio Science; Targeted Oncology
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); EpicentRx; Genentech/Roche (Inst); Henlius (Inst); Mirati Therapeutics (Inst); Novocure (Inst); Pfizer (Inst); Regenxbio (Inst)
 
Prakash Neupane
Research Funding - Merck Sharp & Dohme
 
Weijing Sun
Honoraria - Astellas Pharma; Merck
Consulting or Advisory Role - AstraZeneca; Macrogenics
Research Funding - AstraZeneca (Inst); Merck (Inst); Novella Clinical (Inst)
 
Haoran Li
No Relationships to Disclose